FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Meropenem for Injection, USP
Status: Discontinuation
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Sagent Pharmaceuticals (New 09/05/2018)

Company Contact Information:
866-625-1618

Presentation Posting Date Related Information
500 mg (NDC 25021-155-15) 09/05/2018 Discontinuation of the manufacture of the drug
1 gm (NDC 25021-156-30) 09/05/2018 Discontinuation of the manufacture of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English